Browsing by Author Zuo, Shi
Showing results 1 to 3 of 3
Issue Date | Title | Author(s) |
Dec-2022 | Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors | Lei, Jin; Yan, Tao; Zhang, Linzhi; Chen, Bowen; Cheng, Jiamin; Gao, Xiaoqiang; Liu, Zherui; Li, Yinyin; Zuo, Shi; Lu, Yinying |
2023 | Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma | Lei, Jin; Yang, Sibo; Chen, Bowen; Zhang, Linzhi; Yan, Tao; Yang, Gangqi; Chen, Yue; Li, Yinyin; Lu, Yinying; Zuo, Shi |
9-Dec-2022 | TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure | Lei, Jin; Chen, Bowen; Song, Meiru; Zhang, Linzhi; Zhang, Xinfeng; Gao, Xiaoqiang; Li, Yinyin; Lu, Yinying; Zuo, Shi |